Targacept Inc

-

Assets, Funds, Holdings

Home | Sign Up | Log In
New Features
Latest Fund Raises
Related People
Fund Service Providers
Startup & Company Raises
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Keyboard
Targacept Inc
CIK #0001124105
EDGAR Form CIK 2011 - 2026
10-K [0001124105]
10-Q [0001124105]
3 [0001124105]
4 [0001124105]
8-K [0001124105]
D [0001124105]
SC 13D [0001124105]
SC 13G [0001124105]
Form 13D/13G Filer Form 13D/13G Subject Filed
LUO Ying GYRE Therapeutics Inc [2024-09-06]
Ma Songjiang GYRE Therapeutics Inc [2024-09-06]
GNI Group Ltd Catalyst Biosciences Inc [2023-01-05]
JEC II Associates LLC Catalyst Biosciences Inc [2022-06-21]
Lytton Laurence W Catalyst Biosciences Inc [2022-03-04]
OrbiMed Advisors LLC Catalyst Biosciences Inc [2022-02-11]
Renaissance Technologies LLC Catalyst Biosciences Inc [2022-02-11]
Assenagon Asset Management Sa Catalyst Biosciences Inc [2022-01-18]
Assenagon Asset Management Sa Catalyst Biosciences Inc [2022-01-18]
Acuta Capital Partners LLC Catalyst Biosciences Inc [2021-02-16]
BlackRock Inc Catalyst Biosciences Inc [2021-02-02]
Assenagon Asset Management Sa Catalyst Biosciences Inc [2020-08-06]
Assenagon Asset Management Sa Catalyst Biosciences Inc [2020-08-06]
Stonepine Capital Management LLC Catalyst Biosciences Inc [2020-08-05]
Dimensional Fund Advisors LP Catalyst Biosciences Inc [2020-02-12]
Vanguard Group Inc Catalyst Biosciences Inc [2020-02-11]
22NW LP Catalyst Biosciences Inc [2019-07-24]
Singer Julian D Catalyst Biosciences Inc [2019-07-23]
Integrated Core Strategies US LLC Catalyst Biosciences Inc [2019-07-15]
Mangrove Partners Master Fund Ltd Catalyst Biosciences Inc [2019-05-14]
Barr Wayne Jr Catalyst Biosciences Inc [2019-03-01]
Acuta Capital Partners LLC Catalyst Biosciences Inc [2019-02-14]
Nantahala Capital Management LLC Catalyst Biosciences Inc [2019-02-14]
BlackRock Inc Catalyst Biosciences Inc [2019-02-08]
JFL Capital Management LLC Catalyst Biosciences Inc [2018-08-02]
Point72 Asset Management LP Catalyst Biosciences Inc [2018-06-25]
Nexthera Capital LP Catalyst Biosciences Inc [2018-06-11]
Flynn James E Catalyst Biosciences Inc [2018-02-16]
Acuta Capital Partners LLC Catalyst Biosciences Inc [2018-02-14]
Renaissance Technologies LLC Catalyst Biosciences Inc [2018-02-14]
SIO Capital Management LLC Catalyst Biosciences Inc [2018-02-14]
venBio Select Advisor LLC Catalyst Biosciences Inc [2018-02-12]
RTW Investments LP Catalyst Biosciences Inc [2018-02-05]
Venrock Healthcare Capital Partners II LP Catalyst Biosciences Inc [2018-01-29]
Nexthera Capital LP Catalyst Biosciences Inc [2017-12-27]
SIO Capital Management LLC Catalyst Biosciences Inc [2017-04-19]
Lytton Laurence W Catalyst Biosciences Inc [2017-04-13]
Morgenthaler Partners VIII LP Catalyst Biosciences Inc [2015-08-31]
Essex Woodlands Health Ventures VIII LLC Catalyst Biosciences Inc [2015-08-31]
Healthcare Ventures VIII LP Catalyst Biosciences Inc [2015-08-31]
Johnson & Johnson Catalyst Biosciences Inc [2015-08-28]
Rosetta Capital V LP Catalyst Biosciences Inc [2015-08-28]
Biotechnology Value Fund L P Catalyst Biosciences Inc [2015-08-21]
Biotechnology Value Fund L P Targacept Inc [2015-02-10]
Biotechnology Value Fund L P Targacept Inc [2014-09-05]
RTW Investments LLC Targacept Inc [2014-06-11]
FMR LLC Targacept Inc [2012-04-10]
Form 3/4/5 Subject 2011 - 2026
Weng Dan
GYRE Therapeutics Inc
Nussbaum Rodney L
Zhang Ping
Parry Renate
Carmichael Gordon
Epstein David M
Ye Weiguo
Bergmann Joshua Benjamin
Luo Ying
View All
Insider Transaction (Form 3/4/5) Date Action Shares Price Value ($)
GYRE Therapeutics Inc GYRE
Stock Option (Right to Buy) · derivative
2026-01-07 Grant 50,000 $0.00
GYRE Therapeutics Inc GYRE
Stock Option (Right to Buy) · derivative
2026-01-07 Grant 100,000 $0.00
GYRE Therapeutics Inc GYRE
Stock Option (Right to Buy) · derivative
2025-08-05 Grant 250,000 $0.00
GYRE Therapeutics Inc GYRE
Stock Option (Right to Buy) · derivative
2025-06-04 Grant 26,000 $0.00
GYRE Therapeutics Inc GYRE
Stock Option (Right to Buy) · derivative
2025-06-04 Grant 26,000 $0.00
GYRE Therapeutics Inc GYRE
Stock Option (Right to Buy) · derivative
2025-06-04 Grant 26,000 $0.00
GYRE Therapeutics Inc GYRE
Stock Option (Right to Buy) · derivative
2025-06-04 Grant 26,000 $0.00
GYRE Therapeutics Inc GYRE
Stock Option (Right to Buy) · derivative
2025-06-04 Grant 26,000 $0.00
GYRE Therapeutics Inc GYRE
Common Stock
2025-05-28 Sell 558 $10.07 5,619
GYRE Therapeutics Inc GYRE
Common Stock
2025-05-27 Sell 2,000 $10.28 20,560
GYRE Therapeutics Inc GYRE
Stock Option (Right to Buy) · derivative
2025-05-27 Grant 250,000 $0.00
GYRE Therapeutics Inc GYRE
Common Stock
2025-05-23 Sell 182 $10.24 1,864
GYRE Therapeutics Inc GYRE
Common Stock
2025-05-22 Sell 2,000 $10.97 21,940
GYRE Therapeutics Inc GYRE
Common Stock
2025-05-21 Sell 2,000 $10.83 21,660
GYRE Therapeutics Inc GYRE
Common Stock
2025-05-20 Sell 2,000 $11.25 22,500
GYRE Therapeutics Inc GYRE
Common Stock
2025-05-19 Sell 2,000 $11.11 22,220
GYRE Therapeutics Inc GYRE
Common Stock
2025-05-16 Sell 2,000 $11.31 22,620
GYRE Therapeutics Inc GYRE
Common Stock
2025-05-15 Sell 2,000 $10.68 21,360
GYRE Therapeutics Inc GYRE
Common Stock
2025-05-14 Sell 20 $11.30 226
GYRE Therapeutics Inc GYRE
Common Stock
2025-05-13 Sell 2,000 $11.37 22,740
showing 20 of 200 most recent transactions
Terms | Privacy | Providers | Companies | Guide
tony@aum13f.com